The topoisomerase I inhibitor G1147211C (4) was discovered at Glare We
llcome and shown to have promising anti-cancer properties. In order to
fully assess the clinical potential of 3, an improved synthesis of th
e: drug substance was required. Herein is described a convergent catal
ytic asymmetric synthesis of 4 which utilizes as key steps, two Heck r
eactions, a Sharpless asymmetric dihydroxylation reaction, and a Mitsu
nobu reaction. A 2-chloroquinoline is shown to be a viable substrate f
or the final Heck reaction to generate the camptothecin nucleus. (C) 1
997 Elsevier Science Ltd.